HomeNewsBusinessMarketsTrade Spotlight | What should you do with Laurus Labs, Glenmark Pharma, Ashoka Buildcon, and Vakrangee?

Trade Spotlight | What should you do with Laurus Labs, Glenmark Pharma, Ashoka Buildcon, and Vakrangee?

Here's what Karan Pai of GEPL Capital, recommends investors should do with these stocks when the market resumes trading today

December 28, 2021 / 07:22 IST
Story continues below Advertisement

The market showed smart recovery from the day's low in late morning deals and closed with half a percent gains amid low volumes on December 27, backed by select banking and financials, IT, pharma and auto stocks. Generally volumes remain low in the last week of a year due to the holiday season.

The BSE Sensex climbed nearly 300 points to close above 57,400 levels, and the Nifty50 jumped more than 80 points to close near 17,100 mark, while the broader markets underperformed frontline indices. The Nifty Midcap 100 and Smallcap 100 indices gained 0.44 percent and 0.2 percent.

Story continues below Advertisement

Stocks that were in focus include Laurus Labs which rallied 3.51 percent to Rs 519.25, Glenmark Pharma which gained 2.88 percent at Rs 509.65, and Ashoka Buildcon which surged 10.02 percent to Rs 101.55.

Other stocks that were in action include Vakrangee which jumped 4.64 percent to Rs 43.95, and La Opala RG which was up 2.86 percent at Rs 430.10.